Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin infusion rate and fetal heart rate during CSE labor analgesia
NCT03232918Phase 4Recruiting
- Start
- Feb 2019
- Primary completion
- Dec 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of oxytocin in fetal bradycardia (2 arms). Primary endpoint: Incidence of non-reassuring fetal heart rate tracings at 1.5 hours. Started Feb 2019; status: recruiting.
02
Drugs
oxytocin
03
Conditions
fetal bradycardia
Beyond the preview
Go deeper on NCT03232918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03232918.